Evidence Hub

Involvement of Lipids in the Physicochemical and In Vitro Characteristics of Polymer-lipid Nanoparticles in Cancer Cell Models

Fuh-Ching Franky Liu

TSpace (University of Toronto), 2019

Abstract

Polymer-lipid nanoparticles (PLN) have been a focus in cancer chemotherapy research due to their potential for targeting tumour cells, overcoming drug resistance and reducing toxicity. This work explores the (1) impact of “lipid” component properties and formulation parameters on PLN physicochemical properties and in vitro cytotoxicity using statistical design-of-experiments, and (2) mechanisms of PLN cell entry and organelle distribution, and response to lysosomal environments. These analyses show effects of melting point and chemical structure of multiple fatty acids/esters, and long heat exposure on PLN properties. As a result, a robust PLN system was optimized as a doxorubicin (DOX) delivery system for human glioblastoma U87-MG-RED-FLuc cells. This PLN system demonstrated intracellular internalization by multiple cell mechanisms. Furthermore, mechanistic studies examined the role of not only the optimized PLN in glioblastoma cells, but also in a previously-studied myristic acid-based PLN in breast tumour cells on improved potency over free drug.

How strong is the evidence?

Evidence Hub reads this as a thesis, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free